No attachments available.
FDA - Intent to Sole Source Molecular Operating Environment
Contact and place of performance
Carlton Taylor
Silver Spring, MD 20993
USA
NOTICE OF INTENT TO SOLE SOURCE The U.S. Food and Drug Administration intends to award a sole source contract to Chemical Computing Group ULC to enhance the Division of Applied Regulatory S...
View moreOnly one source, Chemical Computing Group ULC, is capable of fulfilling the Government’s requirement to provide the molecular modeling software package to communicate and provide customizable molecular docking models, computational models updating chemical descriptors, support chemical database management, and provide modeling diverse types of molecules and molecular interactions (organic, metallic, biomolecules).
This notice is not a solicitation or a request for offers. Any potential sources other than Chemical Computing Group ULC may submit a capability statement via email to Carlton Taylor, at [email protected] by 12:00 PM EST on Tuesday June 16, 2026.
Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Oral communications are not acceptable in response to this notice.
A determination by the Government not to compete the proposed procurement based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. A solicitation will not be issued.
The U.S. Food and Drug Administration (FDA), under the Office of the Assistant Secretary for Financial Resources, intends to award a sole source contract to Chemical Computing Group ULC for the Molecular Operating Environment (MOE). This software platform provides cheminformatics and molecular modeling capabilities essential for the Division of Applied Regulatory Science to perform three-dimensional structural analysis. These tools are required to conduct robust evaluations of adverse drug reactions that cannot be adequately assessed using traditional two-dimensional methods. The software package must support customizable molecular docking models, chemical database management, and the modeling of diverse molecular interactions involving organic, metallic, and biomolecules.
This requirement is identified under NAICS 513210 for Software Publishers and PSC 7A20 for IT and Telecom - Application Development Software (Perpetual License Software). There is no set-aside designated for this action, which is being conducted as a single source procurement because Chemical Computing Group ULC is identified as the only source capable of satisfying agency requirements due to specific licensing and technical capabilities. The anticipated period of performance consists of a base year running from June 29, 2026, to June 28, 2027, followed by four one-year option periods that extend the potential end date to June 28, 2031.
Work will be performed in Silver Spring, Maryland, under solicitation number 7571TE26Q00038. Although this notice is not a request for competitive proposals, the government will consider capability statements received by June 16, 2026, at 12:00 PM EST to determine if a competitive procurement is warranted. All submissions must be directed to Carlton Taylor. The government is under no obligation to acknowledge receipt or provide feedback regarding any information submitted in response to this notice.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.